Lonza's Synaffix Collaborates with BigHat Biosciences on the Development of a Machine Learning-Designed ADC
LONZA GROUP AG UNSP/ADR (LZAGY)
NASDAQ:AMEX Investor Relations:
lonza.com/about-lonza/investor-relations.aspx
Company Research
Source: PR Newswire
Commercial license to Synaffix technologies follows a series of successful initial preclinical proof of concept studiesCollaboration underscores Lonza's commitment to helping customers deliver innovative new therapies to patients by offering a comprehensive service offering for differentiated ADCsBigHat's artificial intelligence (AI)/machine learning (ML)-powered antibody design platform, Milliner™ was used to design a highly differentiated antibody that was paired with Synaffix's GlycoConnect™, HydraSpace® and toxSYN® ADC technologies to generate a next-gen ADCAMSTERDAM and BASEL, Switzerland, Nov. 4, 2024 /PRNewswire/ -- Synaffix B.V. ("Synaffix"), a Lonza company (SWX: LONN) focused on commercializing its clinical-stage platform technology for the development of antibody-drug conjugates (ADCs) with best-in-class therapeutic index, today announced that it has licensed its ADC technology to BigHat Biosciences, Inc. ("BigHat"). BigHat will combine Synaffix technology with its world-cl
Show less
Read more
Impact Snapshot
Event Time:
LZAGY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LZAGY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LZAGY alerts
High impacting LONZA GROUP AG UNSP/ADR news events
Weekly update
A roundup of the hottest topics
LZAGY
News
- Elevation Oncology Licenses ADC Technology from Synaffix to Drive Pipeline ExpansionPR Newswire
- Elevation Oncology Licenses ADC Technology from Synaffix to Drive Pipeline ExpansionPR Newswire
- Lonza Group AG (OTCMKTS: LZAGY) was upgraded by analysts at Redburn Atlantic to a "strong-buy" rating.MarketBeat
- Lonza's Synaffix Collaborates with BigHat Biosciences on the Development of a Machine Learning-Designed ADCPR Newswire
- Lonza Group AG (OTCMKTS: LZAGY) was upgraded by analysts at The Goldman Sachs Group, Inc. to a "strong-buy" rating.MarketBeat
LZAGY
Analyst Actions
- 10/17/24 - KEPLER CHEUVREUX